| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 12/03/1997 | EP0809499A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 12/02/1997 | US5693795 Process for the manufacture of 4H-imidazo 1,5-A! 1,4!benzodiazepines |
| 12/02/1997 | US5693762 Humanized immunoglobulins |
| 12/02/1997 | US5693761 Genetic engineering; complementarity zones |
| 12/02/1997 | US5693757 Huntingtin DNA, protein and uses thereof |
| 11/20/1997 | WO1997043238A1 Substituted oxobutyric acids as matrix metalloprotease inhibitors |
| 11/20/1997 | WO1997043237A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 11/13/1997 | WO1997041830A1 Reparation and prevention of fibrotic lesions |
| 11/13/1997 | CA2253919A1 Reparation and prevention of fibrotic lesions |
| 11/12/1997 | EP0806416A1 Huperzine a derivatives, their preparation and their use |
| 11/11/1997 | US5686475 Application of riluzole in the treatment of mitochondrial diseases |
| 11/11/1997 | US5686288 Huntingtin DNA, protein and uses thereof |
| 11/11/1997 | US5686097 Hormone replacement therapy, glycerol monolaurate, lauryl lactate |
| 11/06/1997 | WO1997040679A1 Methods for delivering compounds into a cell |
| 11/06/1997 | CA2252617A1 Methods for delivering compounds into a cell |
| 11/05/1997 | EP0804465A1 Novel elastase inhibitors |
| 11/05/1997 | EP0804196A1 Use of serotonin antagonists (5ht 3?) for treating fibromyalgia |
| 11/05/1997 | EP0804195A2 Depolarizing skeletal muscle relaxants |
| 11/05/1997 | CN1164192A Multicatalytic protease inhibitors |
| 11/05/1997 | CN1163893A Process improvement in synthesis of N-£3-(3-cyanopyrazolo£1,5-alpha| pyrimidin-7-yl) phenyli-N-ethyl-acetamide |
| 11/04/1997 | US5684028 Sulphorous derivatives of imidazole, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions |
| 11/04/1997 | US5684012 Dimeric piperidine, tetrahydropyridine and piperazine derivatives |
| 10/30/1997 | WO1997040066A1 Suppression of immune response via inhibition of cathepsin s |
| 10/30/1997 | WO1997039768A1 A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent |
| 10/30/1997 | WO1997039641A1 Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive |
| 10/30/1997 | CA2251714A1 Suppression of immune response via inhibition of cathepsin s |
| 10/23/1997 | WO1997038986A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 10/22/1997 | EP0802195A2 Substituted 2,3-benzodiazepine derivatives, process and intermediates for their preparation and pharmaceutical compositions comprising them as well as their use |
| 10/22/1997 | EP0801651A1 Hydroxymethylimidazodiazepines and their esters |
| 10/21/1997 | US5679680 α-substituted hydrazides having calpain inhibitory activity |
| 10/21/1997 | US5679650 Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine |
| 10/16/1997 | WO1997038084A2 Polynucleotides derived from a pbmc cdna library encoding secreted proteins |
| 10/16/1997 | WO1997038008A1 6-substituted amino-4-oxa-1-azabicyclo[3,2,0] heptan-7-one deriv atives as cysteine protease inhibitors |
| 10/16/1997 | WO1997037664A2 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders |
| 10/16/1997 | CA2252086A1 6-substituted amino-4-oxa-1-azabicyclo¬3,2,0|heptan-7-one derivatives as cysteine protease inhibitors |
| 10/16/1997 | CA2250874A1 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders |
| 10/16/1997 | CA2250860A1 Polynucleotides encoding secreted proteins |
| 10/14/1997 | US5677419 Cyclic vasoactive peptide analogs |
| 10/14/1997 | US5677321 Anesthetic premedication |
| 10/14/1997 | US5676831 Isoindolinone derivative, preparation thereof and pharmaceutical compositions containing same |
| 10/09/1997 | WO1997037002A1 Promotion of regeneration of organized tissues |
| 10/09/1997 | CA2248729A1 Promotion of regeneration of organized tissues |
| 10/02/1997 | WO1997035852A1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents |
| 10/02/1997 | WO1997035604A1 Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation |
| 09/25/1997 | WO1997035015A2 Tyrosine-phosphatase-related protein |
| 09/25/1997 | WO1997034929A1 Process for extraction of a growth factor complex |
| 09/25/1997 | WO1997034624A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 09/25/1997 | CA2249196A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 09/25/1997 | CA2248843A1 Process for extraction of a growth factor complex |
| 09/24/1997 | EP0796243A1 Diaminocyclobutene-3,4-diones |
| 09/24/1997 | CN1159920A Powder for fracture and trauma |
| 09/23/1997 | US5670527 Cytokine inhibitors useful in treating asthma, osteoporosis, arthritis, inflammation, sepsis, cardiovascular disorders, diabetes, multiple sclerosis, skin disorders |
| 09/18/1997 | WO1997033997A1 Method of treating muscular disorders |
| 09/18/1997 | WO1997033883A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases |
| 09/12/1997 | WO1997032996A1 Direct molecular diagnosis of friedreich ataxia |
| 09/09/1997 | US5665718 Anxiolytic, anticonvulsant, muscle relaxant, sedative, hypnotic agents |
| 09/04/1997 | WO1997031636A1 Novel indole and benzothiazole derivatives |
| 09/04/1997 | CA2246813A1 Novel indole and benzothiazole derivatives |
| 09/02/1997 | US5663334 Process for preparing pyrimidyl imidazoles |
| 09/02/1997 | US5663204 Cholecystokinin and gastrin antagonist for appetite regulators, gastrointestinal disorders and nervous system disorders |
| 08/27/1997 | EP0790999A1 Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments |
| 08/21/1997 | WO1997029775A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist |
| 08/21/1997 | CA2246356A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist |
| 08/20/1997 | EP0789578A1 Multicatalytic protease inhibitors |
| 08/19/1997 | US5658921 Potent sigma receptor ligands; water solubility; symmetry |
| 08/13/1997 | EP0788491A1 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives |
| 08/13/1997 | CN1035615C Process for preparing heteroaryl amines as acetylcholinesterase |
| 08/07/1997 | WO1997028191A1 Mhc complexes and uses thereof |
| 08/07/1997 | WO1997021811A3 Novel tyrosine kinase receptors and ligands |
| 08/07/1997 | CA2244755A1 Mhc complexes and uses thereof |
| 08/06/1997 | EP0786995A1 Use of receptor potentiators |
| 08/05/1997 | US5654306 Piperidine derivative and pharmaceutical composition |
| 07/31/1997 | WO1997026876A1 Methods of increasing sphincter competence |
| 07/31/1997 | WO1997026791A1 METHODS OF MODULATING RADICAL FORMATION BY MUTANT CuZnSOD ENZYMES |
| 07/31/1997 | CA2244711A1 Methods of modulating radical formation by mutant cuznsod enzymes |
| 07/29/1997 | US5652252 Potassium channel activators |
| 07/24/1997 | WO1997026349A1 LEUCYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026345A1 GLUTAMYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026344A1 ASPARTYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026342A1 THREONYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997025977A1 Pharmaceutical compositions |
| 07/24/1997 | WO1997007198A3 Dna sequences and secreted proteins encoded thereby |
| 07/24/1997 | CA2678707A1 Pharmaceutical compositions comprising ascomycin derivatives |
| 07/23/1997 | EP0785271A1 Threonyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785265A1 Aspartyl tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785264A1 Lencyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785261A1 Glutamyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | CN1154853A Wind-dispelling ointment and preparation method thereof |
| 07/17/1997 | WO1997025333A2 Macrocyclic compounds made from suboxide units |
| 07/17/1997 | WO1997025322A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 07/17/1997 | WO1997025046A1 Novel substituted imidazole compounds |
| 07/17/1997 | CA2241870A1 Macrocyclic compounds made from suboxide units |
| 07/16/1997 | EP0783498A1 Substituted aryl piperazines as neurokinin antagonists |
| 07/15/1997 | US5648386 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds |
| 07/10/1997 | DE19600301A1 Bioregulatorischer Wirkstoff, Verfahren zu seiner Herstellung sowie dessen Verwendung Bioregulatory active substance, process for its preparation and its use |
| 07/09/1997 | CN1153785A Cyclic vasoactive peptide analogs |
| 07/03/1997 | WO1997016185A3 A pharmaceutical composition for the treatment of autoimmune diseases |
| 07/01/1997 | US5643586 Skin disorders and antiaging agents |
| 06/26/1997 | WO1997022696A1 Utrophin gene expression |
| 06/26/1997 | WO1997022618A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |